Tender detail

Conclusion of a non-exclusive pharmaceutical discount agreement for Faricimab (ATC S01LA09) for the period 1 October 2026 to 30 September 2028

Summary

The tender concerns the conclusion of non-exclusive pharmaceutical discount agreements for medicines containing the active substance Faricimab (ATC S01LA09). DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible for medicines to be specified by the bidder in Annex 2 to the agreement. The agreements are intended to run from 1 October 2026 to 30 September 2028 and will end automatically if an exclusive agreement for the active substance enters into force.

Reference number
571028-2026
Buyer
DAK-Gesundheit
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-07-28
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.